Registration of securities issued in business combination transactions

Description of Business and Summary of Significant Accounting Policies (Details Narrative) (Supera Pharmaceuticals, Inc.)

v3.20.4
Description of Business and Summary of Significant Accounting Policies (Details Narrative) (Supera Pharmaceuticals, Inc.) - shares
1 Months Ended
Nov. 30, 2020
Dec. 31, 2020
Ownership Percentage   20.00%
Mymd Pharmaceuticals Inc. [Member]    
Ownership Percentage   80.00%
Mymd Pharmaceuticals Inc. [Member] | Asset Purchase Agreement [Member]    
Number of shares issued during period, purchase of assets 33,937,909